Nontraumatic Pure Acute Subdural Hematoma Caused by a Ruptured Cortical Middle Cerebral Artery Aneurysm: Case Report and Literature Review
Abstract
Nontraumatic or “spontaneous” acute subdural hematoma (SDH) is rare, and “pure” acute SDH without subarachnoid hemorrhage (SAH) due to aneurysmal rupture is extremely rare. We report a case of nontraumatic pure acute SDH caused by the rupture of a cortical middle cerebral artery (MCA) aneurysm. A 43-year-old man with no antecedents, except hypertension, presented to the emergency department with acute-onset moderate headache and nausea after swimming. He reported neither preceding head trauma nor dental check-up. Neurological examinations and laboratory tests were unremarkable. Computed tomography (CT) showed an acute SDH on the left convexity without SAH, but both magnetic resonance (MR) angiography and three-dimensional CT (3D-CT) angiography disclosed no vascular abnormality. As he became drowsy, the patient emergently underwent an evacuation of the SDH. Unexpectedly, a small saccular aneurysm of a cortical branch of the left MCA was recognized at surgery. Although indocyanine green (ICG) angiography revealed this aneurysm was thrombosed, a clip was applied on the aneurysmal base. He was discharged home without any complications 21 days after admission. To seek the cause of nontraumatic acute SDH, supplementary examinations including 3D-CT, MR, and/or catheter angiography are necessary. Even if angiography reveals no vascular lesions, the present case warrants that the cortical surface should be meticulously inspected at surgery, because a thrombosed cortical artery…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
- Challenges in Chagas Disease Drug Development
- T Cell Specificity: A Great Challenge in Chagas Disease
- Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice
- Rapid Molecular Detection of Terbinafine-resistant Dermatophytes
- Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.